142P Phase IIIb study of durvalumab plus platinum–etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Title:
142P Phase IIIb study of durvalumab plus platinum–etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Author:
Isla, D. Arriola, E. Garcia Campelo, M.R. Martí, C. Diz Tain, P. Moreno Vega, A.L. Piqueras, M.L-B. León, L. Gutierrez Calderon, V. Oramas Rodriguez, J.M. Majem, M. Sanchez-Hernandez, A. Aguado de la Rosa, C. Alvarez Cabellos, R. Marti-Ciriquian, J.L. Moreno Paul, A. Gonzalez Cordero, M. Callejo Mellén, Á. Baez, L. Zugazagoitia, J.